DEF 14A: Prospect Capital Seeks Stockholder Approval to Sell Shares Below Net Asset Value

Sentiment:

Proxy Statement


Prospect Capital Corporation is asking stockholders to approve a proposal allowing the company to sell shares of its common stock below its net asset value (NAV) under certain conditions.

Capital raiseThe company is seeking authorization to sell shares of its common stock below NAV per share.The maximum number of shares salable below NAV on any given date is limited to 25% of the company's outstanding common stock immediately prior to such sale.There is no maximum level of discount from NAV at which the company may sell shares pursuant to this authority.

Summary

  • Prospect Capital Corporation is seeking stockholder approval to renew its authorization to sell shares of its common stock below the company's net asset value (NAV) per share.
  • The proposal will be voted on at a special meeting of stockholders to be held virtually on June 10, 2024.
  • The authorization, if approved, would be effective for a 12-month period.
  • The company is seeking this authorization to maintain flexibility in accessing capital, particularly in volatile market conditions, and to capitalize on potential investment opportunities.
  • The maximum number of shares that can be sold below NAV on any given date is limited to 25% of the company's outstanding common stock.
  • The company has engaged EQ Fund Solutions, LLC to assist in the solicitation of proxies for the Special Meeting for a fee of approximately $1,304,721.29 plus out-of-pocket expenses.
  • As of March 12, 2024, there were 415,207,492 shares of the Company's common stock outstanding.

Sentiment

Score: 5

Explanation: The document presents a neutral view, outlining both the potential benefits and risks of the proposal to sell shares below NAV. While it emphasizes the need for financial flexibility, it also acknowledges the dilutive effect on existing shareholders.

Positives

  • Approval of the proposal would provide Prospect Capital with greater flexibility to access capital in volatile market conditions.
  • The company believes that selling shares below NAV could allow it to capitalize on investment opportunities and maintain a healthy balance sheet.
  • Increased market capitalization and trading volume may result from issuing additional shares, potentially decreasing stock price volatility.
  • The company may use a portion of the net proceeds from any such offering to repay outstanding borrowings.

Negatives

  • Selling shares below NAV would result in immediate dilution to existing common stockholders.
  • Non-participating stockholders would experience a decrease in NAV per share and a disproportionate decrease in their interest in the company's earnings and assets.
  • The company's investment advisor will benefit from additional investment management fees on the proceeds of such offerings, potentially creating a conflict of interest.
  • There is no maximum level of discount from NAV at which the company may sell shares pursuant to this authority.

Risks

  • Volatility in the capital markets could negatively impact the company's asset valuations, stockholders' equity, and asset coverage ratio.
  • The company's ability to pay dividends, meet debt covenants, and qualify for tax treatment as a RIC could be negatively impacted if it fails to maintain an asset coverage ratio of not less than 150%.
  • The company's shares of common stock have historically traded at both a discount to and a premium over the net assets attributable to those shares.
  • The company may utilize a rights offering pursuant to Section 23(b) of the 1940 Act in order to access the equity markets if we trade below NAV per share.

Future Outlook

The company seeks to maintain consistent access to capital to capitalize on investment opportunities and manage its balance sheet effectively.

Management Comments

  • John F. Barry III, Chief Executive Officer, urges stockholders to submit their proxy as soon as possible.
  • The Board of Directors believes that having the flexibility to sell our common stock below NAV per share in certain instances is in the best interests of stockholders.

Industry Context

Many BDCs have sought and received authorization from their stockholders to sell shares of common stock at prices below NAV.

Comparison to Industry Standards

  • Several BDCs have completed offerings of common stock at prices per share below their respective NAV.
  • The document mentions that many BDCs have sought and received authorization from their stockholders to sell shares of common stock at prices below NAV for similar reasons.

Stakeholder Impact

  • Existing stockholders may experience dilution if the proposal is approved and the company sells shares below NAV.
  • The company's investment advisor will benefit from additional investment management fees on the proceeds of such offerings.
  • The company's ability to capitalize on investment opportunities and maintain a healthy balance sheet could be enhanced if the proposal is approved.

Next Steps

  • Stockholders are urged to vote on the proposal to authorize the sale of shares below NAV.
  • The company will hold a special meeting of stockholders on June 10, 2024, to vote on the proposal.
  • The Board of Directors will consider the potential dilutive effect of the issuance of shares at a price below the NAV per share when considering whether to authorize any such issuance.

Key Dates

DateDescription
2024-03-12Record date for the Special Meeting
2024-03-15Proxy Statement and accompanying proxy card first being sent to stockholders on or about this date.
2024-05-28Deadline for stockholder proposals pursuant to Rule 14a-8 under the Exchange Act to be received at our principal executive offices in order to be eligible to be included in the Company's proxy statement and proxy card for the 2024 Annual Meeting of Stockholders.
2024-06-03Deadline for stockholders of record to contact EQ Fund Solutions, LLC to request a control number to participate in the Special Meeting.
2024-06-10Date of the Special Meeting of Stockholders

Keywords

Prospect Capital, NAV, stockholder approval, common stock, dilution, capital markets, proxy statement, special meeting, investment company, BDC

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.